MOLINA HEALTHCARE INC (MOH) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:MOH - US60855R1005 - Common Stock
168.5 USD
+1.6 (+0.96%)
167.114 USD
-1.39 (-0.82%)
MOH gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 100 industry peers in the Health Care Providers & Services industry. MOH has an average financial health and profitability rating. MOH has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
MOH had positive earnings in the past year.
MOH had a negative operating cash flow in the past year.
Each year in the past 5 years MOH has been profitable.
Each year in the past 5 years MOH had a positive operating cash flow.
1.2 Ratios
MOH has a Return On Assets of 5.62%. This is in the better half of the industry: MOH outperforms 80.00% of its industry peers.
The Return On Equity of MOH (21.07%) is better than 88.00% of its industry peers.
MOH has a better Return On Invested Capital (11.98%) than 87.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MOH is significantly above the industry average of 9.44%.
The 3 year average ROIC (17.96%) for MOH is well above the current ROIC(11.98%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.62% | ||
| ROE | 21.07% | ||
| ROIC | 11.98% |
ROA(3y)7.1%
ROA(5y)6.75%
ROE(3y)26.28%
ROE(5y)27.2%
ROIC(3y)17.96%
ROIC(5y)17.65%
1.3 Margins
MOH has a Profit Margin of 1.98%. This is in the better half of the industry: MOH outperforms 61.00% of its industry peers.
MOH's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 2.97%, MOH is in line with its industry, outperforming 55.00% of the companies in the same industry.
MOH's Operating Margin has declined in the last couple of years.
MOH's Gross Margin of 13.91% is on the low side compared to the rest of the industry. MOH is outperformed by 67.00% of its industry peers.
MOH's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.97% | ||
| PM (TTM) | 1.98% | ||
| GM | 13.91% |
OM growth 3Y1.53%
OM growth 5Y-7.6%
PM growth 3Y6.92%
PM growth 5Y-7.91%
GM growth 3Y1.48%
GM growth 5Y-2.5%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so MOH is creating value.
The number of shares outstanding for MOH has been reduced compared to 1 year ago.
The number of shares outstanding for MOH has been reduced compared to 5 years ago.
MOH has a worse debt/assets ratio than last year.
2.2 Solvency
MOH has an Altman-Z score of 4.29. This indicates that MOH is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of MOH (4.29) is better than 78.00% of its industry peers.
A Debt/Equity ratio of 0.92 indicates that MOH is somewhat dependend on debt financing.
MOH has a Debt to Equity ratio of 0.92. This is comparable to the rest of the industry: MOH outperforms 41.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.92 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 4.29 |
ROIC/WACC1.45
WACC8.25%
2.3 Liquidity
A Current Ratio of 1.68 indicates that MOH should not have too much problems paying its short term obligations.
The Current ratio of MOH (1.68) is better than 64.00% of its industry peers.
MOH has a Quick Ratio of 1.68. This is a normal value and indicates that MOH is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of MOH (1.68) is better than 69.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.68 | ||
| Quick Ratio | 1.68 |
3. Growth
3.1 Past
MOH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.06%.
MOH shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 14.16% yearly.
MOH shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.65%.
MOH shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.29% yearly.
EPS 1Y (TTM)-16.06%
EPS 3Y18.68%
EPS 5Y14.16%
EPS Q2Q%-69.38%
Revenue 1Y (TTM)13.65%
Revenue growth 3Y13.54%
Revenue growth 5Y19.29%
Sales Q2Q%11%
3.2 Future
Based on estimates for the next years, MOH will show a small growth in Earnings Per Share. The EPS will grow by 4.82% on average per year.
The Revenue is expected to grow by 5.46% on average over the next years.
EPS Next Y-36.41%
EPS Next 2Y-22.61%
EPS Next 3Y-9.96%
EPS Next 5Y4.82%
Revenue Next Year10.73%
Revenue Next 2Y7.54%
Revenue Next 3Y7.33%
Revenue Next 5Y5.46%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 9.13, the valuation of MOH can be described as reasonable.
94.00% of the companies in the same industry are more expensive than MOH, based on the Price/Earnings ratio.
MOH's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.54.
MOH is valuated correctly with a Price/Forward Earnings ratio of 12.42.
Based on the Price/Forward Earnings ratio, MOH is valued cheaper than 85.00% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.78, MOH is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.13 | ||
| Fwd PE | 12.42 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | -0.16 |
4.3 Compensation for Growth
MOH has a very decent profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as MOH's earnings are expected to decrease with -9.96% in the coming years.
PEG (NY)N/A
PEG (5Y)0.64
EPS Next 2Y-22.61%
EPS Next 3Y-9.96%
5. Dividend
5.1 Amount
No dividends for MOH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
168.5
+1.6 (+0.96%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners113.09%
Inst Owner Change12.27%
Ins Owners1.33%
Ins Owner Change1.12%
Market Cap8.66B
Revenue(TTM)44.55B
Net Income(TTM)883.00M
Analysts56.3
Price Target174.39 (3.5%)
Short Float %7.61%
Short Ratio2.27
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-29.8%
Min EPS beat(2)-53.34%
Max EPS beat(2)-6.27%
EPS beat(4)1
Avg EPS beat(4)-17.79%
Min EPS beat(4)-53.34%
Max EPS beat(4)1.06%
EPS beat(8)4
Avg EPS beat(8)-7.75%
EPS beat(12)8
Avg EPS beat(12)-3.04%
EPS beat(16)12
Avg EPS beat(16)-1.32%
Revenue beat(2)2
Avg Revenue beat(2)3.64%
Min Revenue beat(2)3.29%
Max Revenue beat(2)3.99%
Revenue beat(4)4
Avg Revenue beat(4)2.53%
Min Revenue beat(4)0.69%
Max Revenue beat(4)3.99%
Revenue beat(8)8
Avg Revenue beat(8)3.12%
Revenue beat(12)10
Avg Revenue beat(12)2.26%
Revenue beat(16)14
Avg Revenue beat(16)2.23%
PT rev (1m)-8.49%
PT rev (3m)-16.8%
EPS NQ rev (1m)-45.19%
EPS NQ rev (3m)-84.92%
EPS NY rev (1m)-4.2%
EPS NY rev (3m)-25.1%
Revenue NQ rev (1m)0.49%
Revenue NQ rev (3m)-0.85%
Revenue NY rev (1m)-0.17%
Revenue NY rev (3m)0.67%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.13 | ||
| Fwd PE | 12.42 | ||
| P/S | 0.19 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 2.07 | ||
| P/tB | 4.35 | ||
| EV/EBITDA | -0.16 |
EPS(TTM)18.45
EY10.95%
EPS(NY)13.57
Fwd EY8.05%
FCF(TTM)-11.17
FCFYN/A
OCF(TTM)-8.97
OCFYN/A
SpS866.73
BVpS81.54
TBVpS38.7
PEG (NY)N/A
PEG (5Y)0.64
Graham Number183.98
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.62% | ||
| ROE | 21.07% | ||
| ROCE | 16.11% | ||
| ROIC | 11.98% | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | 2.97% | ||
| PM (TTM) | 1.98% | ||
| GM | 13.91% | ||
| FCFM | N/A |
ROA(3y)7.1%
ROA(5y)6.75%
ROE(3y)26.28%
ROE(5y)27.2%
ROIC(3y)17.96%
ROIC(5y)17.65%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)24.15%
ROCE(5y)23.74%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y1.53%
OM growth 5Y-7.6%
PM growth 3Y6.92%
PM growth 5Y-7.91%
GM growth 3Y1.48%
GM growth 5Y-2.5%
F-Score4
Asset Turnover2.84
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.92 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 2.53 | ||
| Cap/Depr | 56.78% | ||
| Cap/Sales | 0.25% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.68 | ||
| Quick Ratio | 1.68 | ||
| Altman-Z | 4.29 |
F-Score4
WACC8.25%
ROIC/WACC1.45
Cap/Depr(3y)51.53%
Cap/Depr(5y)59.49%
Cap/Sales(3y)0.26%
Cap/Sales(5y)0.29%
Profit Quality(3y)92.3%
Profit Quality(5y)171.56%
High Growth Momentum
Growth
EPS 1Y (TTM)-16.06%
EPS 3Y18.68%
EPS 5Y14.16%
EPS Q2Q%-69.38%
EPS Next Y-36.41%
EPS Next 2Y-22.61%
EPS Next 3Y-9.96%
EPS Next 5Y4.82%
Revenue 1Y (TTM)13.65%
Revenue growth 3Y13.54%
Revenue growth 5Y19.29%
Sales Q2Q%11%
Revenue Next Year10.73%
Revenue Next 2Y7.54%
Revenue Next 3Y7.33%
Revenue Next 5Y5.46%
EBIT growth 1Y-19.56%
EBIT growth 3Y15.28%
EBIT growth 5Y10.22%
EBIT Next Year-31.67%
EBIT Next 3Y-9.72%
EBIT Next 5YN/A
FCF growth 1Y-128.12%
FCF growth 3Y-35.66%
FCF growth 5Y7.61%
OCF growth 1Y-121.54%
OCF growth 3Y-32.77%
OCF growth 5Y8.21%
MOLINA HEALTHCARE INC / MOH FAQ
What is the fundamental rating for MOH stock?
ChartMill assigns a fundamental rating of 5 / 10 to MOH.
Can you provide the valuation status for MOLINA HEALTHCARE INC?
ChartMill assigns a valuation rating of 4 / 10 to MOLINA HEALTHCARE INC (MOH). This can be considered as Fairly Valued.
How profitable is MOLINA HEALTHCARE INC (MOH) stock?
MOLINA HEALTHCARE INC (MOH) has a profitability rating of 6 / 10.
What is the financial health of MOLINA HEALTHCARE INC (MOH) stock?
The financial health rating of MOLINA HEALTHCARE INC (MOH) is 5 / 10.
What is the earnings growth outlook for MOLINA HEALTHCARE INC?
The Earnings per Share (EPS) of MOLINA HEALTHCARE INC (MOH) is expected to decline by -36.41% in the next year.